MeSH D004374 - patent ductus arteriosus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Indomethacin | Indo-lemmon | 1985-11-07 | |||
| Indomethacin | Indomethacin | 1988-04-18 | ||||
| Novast Laboratories | Indomethacin | Indomethacin | 2017-05-08 | |||
| Glenmark Pharmaceuticals | Indomethacin | Indomethacin | 2010-12-22 | |||
| Sandoz | Indomethacin | Indomethacin | 1987-04-29 | |||
| Genus Lifesciences | Indomethacin | Tivorbex | 2030-04-23 | 2014-02-24 | ||
| Pfizer | Indomethacin | Indomethacin | 1984-11-23 | |||
| Cosette Pharmaceuticals | Indomethacin | Indomethacin | 1992-08-31 | |||
| Aurobindo Pharma | Indomethacin | Indomethacin | 2016-12-27 | |||
| Rising Pharmaceuticals | Indomethacin | Indomethacin | 1985-09-04 | |||
| Mylan | Indomethacin | Indomethacin | 2014-03-20 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%10/10
Phase 2
92%11/12
Phase 3
88%14/16
Approved: 4Overall Success rate: 80%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use